{"brief_title": "Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices", "brief_summary": "This trial is for patients with a central venous catheter (a vascular access device) that is not functioning properly (unable to withdraw blood). The trial compares a new blood clot dissolving agent (alfimeprase) against the currently used treatment.", "condition": "Catheters, Indwelling", "intervention_type": "Drug", "intervention_name": "Alfimeprase", "criteria": "Subjects must: - have a dysfunctional Central Venous Access Device (CVAD) defined as unable to withdraw 3 mL blood - have had the device in place for > 48 hours - be clinically stable - be 18 or older - give informed consent", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00073515.xml"}